NEW ISSUE
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Optimising the delivery of self-expanding valves according to vascular access
November 20, 2020
Showing 1-8 of 8 articles
Interventions for valvular disease
Impact of mitral valve treatment choice on mortality according to aetiology April 16, 2019 | 10.4244/EIJ-D-18-00874
Coronary interventions
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial August 4, 2017 | 10.4244/EIJ-D-17-00261
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
March 20, 2015 | 10.4244/EIJY14M08_07
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
February 21, 2012 | 10.4244/EIJV7I10A190
Triggering mechanisms of stent thrombosis
January 20, 2011